期刊文献+

多烯紫杉醇诱导细胞周期阻断与凋亡过程的模型 被引量:2

Mathematical model for analysis of cell cycle arrest and apoptosis induced by docetaxel
下载PDF
导出
摘要 以多烯紫杉醇诱导白血病细胞株K562为对象,建立了描述肿瘤细胞生长及其与药物作用关系的细胞周期数学模型,研究了多烯紫杉醇诱导K562细胞周期变化与凋亡现象及量效关系.结果表明,多烯紫杉醇引起K562细胞M期阻断和诱导细胞凋亡的饱和浓度分别为17.96、7.82 nmol·L-1,有效浓度分别为2.63、1.69 nmol·L-1;低浓度(1.69~2.63 nmol·L-1)的多烯紫杉醇直接诱导细胞凋亡而不引起明显的M期阻断;高浓度(>7.82 nmol·L-1)的多烯紫杉醇主要效应是促进细胞M期阻断.本模型揭示出M期阻断与凋亡无显著的相关性,为多烯紫杉醇的作用机制提供了一个新的解释. A mathematical model of in vitro cancer cell growth differentiated by cell cycle distribution and antimitotic drug interaction was presented. The model was adapted to the growth and treatment of human leukemia K562 cells with docetaxel. It described docetaxel-induced apoptosis, G2/M phase arrest as well as the relationship of drug concentration and cell response manners. The model showed that the saturation docetaxel concentrations to cause M-phase arrest and apoptosis in K562 cells were 17.96 nmol&middotL-1 and 7.82 nmol&middotL-1 and the effective concentrations were 2.63 nmol&middotL-1 and 1.69 nmol&middotL-1, respectively. Low concentration docetaxel (1.69-2.63 nmol&middotL-1) induced apoptosis directly, without obvious M-phase arrest, while cells mainly reacted with concentration-dependent M-phase arrest and saturated apoptosis at high concentration docetaxel (> 7.82 nmol&middotL-1). The model indicated that M-phase arrest was not positively related to apoptosis, which gave a new explanation for the mechanism of docetaxel.
出处 《化工学报》 EI CAS CSCD 北大核心 2005年第5期904-910,共7页 CIESC Journal
基金 国家自然科学基金资助项目 (20176038)~~
关键词 多烯紫杉醇 白血病细胞 细胞凋亡 细胞周期 数学模型 Cell culture Concentration (process) Disease control Human engineering Mathematical models
  • 相关文献

参考文献3

二级参考文献11

共引文献45

同被引文献18

  • 1Yuan Yingjin(元英进),Ge Zhiqiang(葛志强),Feng Xia(冯霞).Anticancer New Drugs:Paclitaxel and Docetaxel(抗癌新药紫杉醇与多烯紫杉醇)[M].Beijing:Chemical Industry Press,2002:122.
  • 2Kim CH,Yoo JS,Lee CT,et al.FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells[J].Int J Cancer,2006,118(7):1692.
  • 3Lu KH,Lue KH,Liao HH,et al.Induction of Caspase-3-de-pendent apoptosis in human leukemia HL-60 cells by paclitaxel[J].Clin Chim Acta,2005,357(1):65.
  • 4Milross C G,Mason K A,Hunter N R,et al.Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel[J].Natl.Cancer Inst,1996,88:1308-1314.
  • 5Rao S, He LF, Chakravarty S, et al. Characterization of the Taxol Binding Site on the Microtubule. The Journal of Biological Chemistry, 1999, 274(53) :37990-37994.
  • 6Alberto M, Frank F, Gabriel H, et al. Docetaxel for treatment of solid tumours., a systematic review of clinical data. Lancet Oncol, 2005, 6:229-239.
  • 7Cristinao F, Giusepplna R, Simona M, et al. The Seco--Taxane IDN5390 Is Able to Target Class III β--Tubulin and to Overcome Paclitaxel Resistance. Cancer Res, 2005, 65(6) :2397-2405.
  • 8Zhu J, Beattie EC, Yang Y, et al. Centrosome impairments and consequent cytokinesis defects are possible mechanisms of taxane drugs. Anticancer Res, 2005, 25 (3B) : 1919-1925.
  • 9Sudo T, Nitta M, Saya H, et al. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res, 2004, 64(7) :2502-2508.
  • 10Zhao JS, Kim JE, Reed E, et al. Molecular mechanism of antitumor activity of taxanes in lung cancer (Review). International Journal of Oncology, 2005, 27:247-256.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部